A progress in neuroimaging research on the central mechanisms of botulinum toxin in the treatment of focal dystonia
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 7
Abstract
Botulinum toxin (BoNT) is currently the first-line method for treating focal dystonia, which causes muscle paralysis by chemical denervation. Recent neuroimaging studies have found that BoNT treatment could alter neuroplasticity in the brain of patients with focal dystonia. However, the specific central nervous system mechanisms have not been fully elucidated. To this end, here we review the neuroimaging studies on BoNT treatment for dystonia from three aspects: functional magnetic resonance imaging, structural magnetic resonance imaging, and positron emission tomography imaging. It suggests that BoNT may improve the symptoms of dystonia patients by affecting functional connectivity, microstructure, and metabolic levels of the cortex, basal ganglia, thalamus, and cerebellum, etc. Therefore, this review will provide a theoretical reference for further exploring the mechanism and developing potential therapeutic targets of dystonia.
Authors and Affiliations
Qinying MU, Junhao HU, Fuhao MA, Hao WANG, Weikang DOU, Liyi CHI, Ming. SHI
Keywords
Related Articles
- EP ID EP750521
- DOI 10.3969/j.issn.1002-0152.2024.07.008
- Views 96
- Downloads 0
Study on the mechanism of losartan reducing the risk of comorbid depression in epileptic rats
[Objective] To investigate the effectiveness and mechanisms of losartan in improving comorbid depression in epileptic rats. [Methods] Male rats were randomly divided into three groups: The losartan-pilocarpine group (PL-...
Advances in the diagnosis and treatment of chronic subdural hematoma
Chronic subdural hematoma is one of the common central nervous system diseases in middle-aged and elderly people, and the incidence is increasing year by year. Drill and drain surgery is recognized as one of the effectiv...
A metabolome-wide case-control study of social anxiety disorder in patients with schizophrenia
[Objective] To explore the metabolic markers of social anxiety disorder in schizophrenia patients with social anxiety disorder through metabolomic sequencing analysis. [Methods] From December 2022 to December 2023, a cas...
Case report of primary coenzyme Q10 deficiency caused by COQ8A gene mutation
Primary coenzyme Q10 deficiency is an autosomal recessive disorder caused by mutations in the genes encoding key enzymes in the biosynthesis of CoQ10. This paper reports for the first time a primary CoQ10 deficiency caus...
Tubular aggregates in systemic lupus erythematosus: A case report and review of literature
Tubular aggregates (TA) are ultrastructural abnormalities in muscle biopsies, which can be detected in muscle biopsy specimens from patients with a variety of hereditary and acquired disorders. A 34-year-old male patient...